Skip to content

Insider · CIK 0001652936

Allan M. Fox

director

Files at RGNX (REGENXBIO Inc.). First filing -, latest -.

In brief

Allan M. Fox files SEC Form 4 as director at RGNX (REGENXBIO Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Allan M. Fox has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 6 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 29, 2026RGNX
REGENXBIO Inc.
AGrant or award
Common Stock
+9,807$0.00$028,861Jun 2, 2026
May 29, 2026RGNX
REGENXBIO Inc.
AGrant or award
Stock Options (Right to Buy)derivative
+46,600$0.00$046,600Jun 2, 2026
May 30, 2025RGNX
REGENXBIO Inc.
AGrant or award
Common Stock
+7,768$0.00$019,054Jun 3, 2025
May 30, 2025RGNX
REGENXBIO Inc.
AGrant or award
Stock Options (Right to Buy)derivative
+39,815$0.00$039,815Jun 3, 2025
May 31, 2024RGNX
REGENXBIO Inc.
AGrant or award
Common Stock
+4,790$0.00$011,286Jun 4, 2024
May 31, 2024RGNX
REGENXBIO Inc.
AGrant or award
Stock Options (Right to Buy)derivative
+24,454$0.00$024,454Jun 4, 2024

Questions about Allan M. Fox

Answered from the filings on this page, as of the latest one.

Is Allan M. Fox buying or selling?

Allan M. Fox has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Allan M. Fox's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Allan M. Fox has 0.

Where does Allan M. Fox file Form 4?

Allan M. Fox has filed Form 4 at RGNX (REGENXBIO Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Allan M. Fox: insider trades and track record | InsiderTell